Company intelligence / Profile preview

Vvital Biomed

Misgav, Northern District, Israelil.linkedin.com ↗

Ownership: Private
Development stage: Preclinical

Overview

Vvital Biomed develops a novel technology for transcatheter mitral valve repair that aims to be minimally affected by systolic pressure load. No published clinical results as of the latest reports.

Therapeutic areas: Cardiovascular
Modalities: Device
Industry: Therapeutic Medical Devices

Partnerships

The Trendlines Group Ltd. [incubator/investor relationship]

Beyond the preview

Go deeper on Vvital Biomed.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vvital Biomed.

Explore the full profile